INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 449m ago
HOUSE PTR49m ago
SEC 13F48m ago
ROBINHOOD CHAIN48m ago
Public company

GLOBUS MEDICAL INC

GMEDCIK 0001237831

EDGAR filingsOpen in network
Price$71.05
1 year+15.5%
Disclosed transactions4
Buys / sells3 / 1
Max Insider Score28
Connections with evidence5

GMED · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
RD
Rhoads Ann DDirector
GMEDGLOBUS MEDICAL INC
Open-market sale · 10b5-1 plan
SELL$425K
5,000 sh
Nov 4, 2026Nov 5, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Rhoads Ann DDirector · Form 144 · Nov 3, 2026
  • ← Holds over 5% ofevidence
    Vanguard Capital Management4.43% of class · Schedule 13G · Oct 29, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-09-10 · Sep 10, 2026
  • ← Lobbied forevidence
traded Nov 4, 2026
+1d
SEC FORM 4

Evidence

24
Gilbert Ray Cisneros, Jr.DSelf
GMEDGLOBUS MEDICAL INC
Purchase
BUY$1,001 – $15KSep 3, 2026Oct 12, 2026
traded Sep 3, 2026
+39dHOUSE PTR

Evidence

24
Gilbert Ray Cisneros, Jr.DSelf
GMEDGLOBUS MEDICAL INC
Purchase
BUY$15K – $50KAug 19, 2026Sep 10, 2026
traded Aug 19, 2026
+22dHOUSE PTR

Evidence

28
Gilbert Ray Cisneros, Jr.DSelf
GMEDGLOBUS MEDICAL INC
Purchase
BUY$1,001 – $15KMar 3, 2026Apr 7, 2026
traded Mar 3, 2026
+35dHOUSE PTR

Evidence

BALLARD SPAHR LLP
LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026

Planned sales and 5% stakes

Form 144, 13D and 13G
  • RDRHOADS ANN DDirector · sale around Nov 4, 2026 · 5,000 shares · 10b5-1 plan$425KForm 144 · filed Nov 4, 2026
  • VMVanguard Capital ManagementPassive holder · crossed on Sep 30, 2026 · 5.96M shares4.43% of class13G amendment · filed Oct 30, 2026

Lobbying

$0 reported · de-duplicated
2026 Q2 $0 via firms2026 Q1 $0 via firms
  • BALLARD SPAHR LLP—2026 Q1 · posted Aug 26, 2026 ·
  • BALLARD SPAHR LLP—2026 Q2 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.